Sleep Duration and Type 2 Diabetes Risk

Variations in habitual sleep duration have emerged as a significant determinant of metabolic health, with both short and long sleep linked to elevated risk of developing type 2 diabetes mellitus (T2DM). Epidemiological cohorts across North America, Europe and Asia have consistently demonstrated a U-shaped relationship, whereby obtaining fewer than six hours or more than nine hours of sleep per night confers higher incidence of T2DM. Mechanistic investigations indicate that insufficient sleep disrupts insulin sensitivity, β-cell function and energy homeostasis, while oversleeping may reflect underlying illness or contribute to sedentary behaviour. Acute sleep restriction experiments reveal impaired glucose tolerance and elevated evening cortisol, whereas interventions that extend sleep duration yield improvements in fasting insulin and postprandial glycaemic profiles. These findings underscore the dual role of sleep quantity and quality in modulating glucose metabolism, and they point to sleep optimisation as a practical, low-cost strategy for diabetes prevention and management on a global scale. Public-health efforts to integrate sleep hygiene into lifestyle guidelines may therefore yield considerable benefits in curbing the rising tide of T2DM.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Sleep Duration and Type 2 Diabetes Risk publication trend

The graph below shows the total number of articles in sleep duration and type 2 diabetes risk across all publications each year (not limited to Nature Index journals).

Technical terms

Insulin resistance: Reduced responsiveness of peripheral tissues to insulin, leading to impaired glucose uptake and elevated blood glucose levels.

Glycaemic control: The maintenance of blood glucose concentrations within a specified target range over time.

Postprandial glycaemia: The rise in blood glucose levels measured following a meal.

Mendelian randomisation: A genetic epidemiology method that uses genetic variants as proxies for modifiable exposures to infer causality.

Sleep efficiency: The proportion of time spent asleep relative to the total time spent in bed, expressed as a percentage.

References

1. The links between sleep duration, obesity and type 2 diabetes mellitus. Journal of Endocrinology (2021).
2. Short Sleep Duration Is Associated with Risk of Future Diabetes but Not Cardiovascular Disease: a Prospective Study and Meta-Analysis. PLOS ONE (2013).
3. Association Between Sleep Duration and Diabetes in Black and White Adults. Diabetes Care (2013).
4. Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health (2007).
5. The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus. Healthcare (2019).
6. Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions. Diabetologia (2021).
7. Investigating Causal Relations Between Sleep-Related Traits and Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study. Frontiers in Genetics (2020).